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Abstract: 
Introduction: The eye is a fascinating organ for several reasons. It is not only have a composite structure, however it is 
considered an immune-privileged organ. The anatomy of the eye is composed of the anterior and posterior parts, the line of 
division is posterior to the lens. The anterior chamber lies within the anterior segment and is an immuneprivileged anatomical 
location, this is due to the fact that the T-cell response in this area is suppressed This protects the eye from potentially destructive 
immune attacks however it also makes defence against infectious agents challenging, particularly where T-cell responses are 
critical for immunological defence. Viruses could get into the eye by direct inoculation, or through haematogenous or neuronal 
spread. The diagnoses of viral eye infections are usually clinical one,  helped by taking a thorough history and performing 
ophthalmic examination. But in challenging cases the lab tests are essential. In this review, we will discuss the most recent 
evidence regarding Causes and management of viral eye infection 
Aim of work: In this review, we will discuss the most recent evidence regarding Causes and management of viral eye infection 
Methodology: We did a systematic search for Causes and management of viral eye infection using PubMed search engine 
(http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com). All relevant studies were 
retrieved and discussed. We only included full articles. 
Conclusions: A wide range of of viruses can affect the eye and cause viral eye infections, either as a primary infection or 
reactivation. Some affect the eye directly while the others indirectly but may still manifest with eye disease. One virus may affect 
several parts of the eye, while different viruses may cause the same eye disease. This could complicate the clinical diagnosis of 
viral eye disease, but the lab tests like PCR and antibody tests could assist in challenging cases where there may be diagnostic 
dilemma. 
The HIV epidemic has had an huge impact on ophthalmology clinics, this is because the virus can  cause different eye diseases, 
and the associated decrease in cell-mediated immunity makes the person highly susceptible to opportunistic viral eye infections, 
sometimes with severe morbidity. There could be other viruses that may affect the eye that we did not discuss. 
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INTRODUCTION: 
The eye is a fascinating organ for several reasons. It 
is not only have a composite structure, however it is 
considered an immune-privileged organ. The 
anatomy of the eye is composed of the anterior and 
posterior parts, the line of division is posterior to the 
lens. The anterior chamber lies within the anterior 
segment and is an immuneprivileged anatomical 
location, this is due to the fact that the T-cell 
response in this area is suppressed [1]. This protects 
the eye from potentially destructive immune attacks 
however it also makes defence against infectious 
agents challenging, particularly where T-cell 
responses are critical for immunological defence. 
Viruses could get into the eye by direct inoculation, 
or through haematogenous or neuronal spread. The 
diagnoses of viral eye infections are usually clinical 
one,  helped by taking a thorough history and 
performing ophthalmic examination. But in 
challenging cases the lab tests are essential. In this 
review, we will discuss the most recent evidence 
regarding Causes and management of viral eye 
infection 
METHODOLOGY: 
We did a systematic search for Causes and 
management of viral eye infection using PubMed 
search engine (http://www.ncbi.nlm.nih.gov/) and 
Google Scholar search engine 
(https://scholar.google.com). All relevant studies 
were retrieved and discussed. We only included full 
articles. 
The terms used in the search were: Causes, 
management, viral eye infection.  
 
HIV and The Eye 
 
HIV is considered a Retroviridae. It is now spread 
globally, especially in the sub-Saharan Africa. The 
transmission often happens after unprotected sex or 
from mother-to-child. The virus causes immune 
suppression eventually if not treated, which makes 
the patient vulnerable to a widespread range of 
infections, this can affect any part of the body, 
as well as the eye. It is projected that about seventy 
percent of adult AIDS patients will develop an ocular 
complication during their lifetime [2]. Typically, the 
main groups of ophthalmic manifestations include 
but not limited to: microvasculopathy, opportunistic 
infections, neoplasms and neuroophthalmic illnesses 
[3]. Microvasculopathy could affect the conjunctiva 
or retina, also known as HIV retinopathy, and could 
present on fundoscopy as cotton wool spots, 
intraretinal haemorrhages and retinal 
microaneurysms [4]. It is suggested that the 
pathological reason behind conjunctival and retinal 
microvasculopathy is potentially alike and could 
involve increased plasma viscosity, circulating 
immune complexes and infectious damage of the 
vasculature. 
 
Orbital and adnexal presentations of HIV are rare, 
with Kaposi sarcoma, conjunctival 
microvasculopathy and opportunistic viral infections 
are the most 
common. The likely opportunistic viral infections 
that could infect the eye involve CMV, HSV, VZV, 
Molluscum contagiosum and many others, though the 
bacterial and fungal infections are also critical [5]. 
Additionally, infectious complications, HIV could 
cause optic neuropathies by different mechanisms, 
including but not limited to compression of the optic 
nerve by cancers, and vaso-occlusion. 
 
In pediatric population, eye manifestations of HIV 
are less often than in adults. The reasons are not so 
clear, with the most common eye manifestation of 
HIV in kids is keratoconjunctivitis sicca or dry eyes 
[6]. 
 
The immune-recovery uveitis is a syndrome that has 
been known as the advent of highly active 
antiretroviral therapy (HAART). It involves 
paradoxical worsening of intraocular inflammation, 
which could be caused by an immune response to 
CMV and other infectious agents present in the eye, 
and is characterised by an increase in 
CD4+ cell count to above one hundred cells/mm3. 
 
The Herpesviruses  
 
Herpesviridae family viruses are large; they are 
double-stranded DNA viruses, which form a large 
and very important group of infective agents. In 
humans, they can cause a wide range of syndromes, 
ranging from the mild to severe. 
 
Herpes simplex viruses 
 
The transmission of HSV-1 and 2 are through close 
contact. HSV-1 can get into the host through the 
oropharyngeal mucosa, that lets the initial replication, 
but could also be transmitted through sexual 
intercourse. This is can be followed by latency in the 
trigeminal or sacral ganglia. The Initial HSV-2 
replication is often in the genital mucosa, with 
latency in the sacral ganglia, and could be linked to 
congenital HSV-2 infection, which might have ocular 
manifestations, such as cataract [7]. HSV-1 and 2 
have a similar clinical presentations and can cause a 
wide spectrum of illnesses. HSV-1, but prevails with 
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regard to eye infections compared with its type two 
counterpart. 
HSV-1 Infection can cause keratitis, which is the 
single most common cause of infectious blindness in 
developed countries [8] and herpetic infections have 
the same exact characteristics of HSV disease 
elsewhere in the body. The primary infection could 
be followed by intermittent reactivation [9] 
  
The reactivation episodes could be responses to 
different stimuli, including fever, stress, cold and 
others, and are maybe due to the viruses’ capability 
to remain latent in the sensory ganglia of the first 
division of the trigeminal nerve. 
 
 
The pathological manifestations of HSV-1 include 
but not limited to blepharitis, conjunctivitis, 
infectious epithelial keratitis, neurotrophic 
keratopathy, necrotizing stromal keratitis, immune 
stromal keratitis and endotheliitis. Dendritic ulcer 
caused by HSV-1 is a form of infectious epithelial 
keratitis and occurs due to active viral replication. 
Other eye manifestations are iridocyclitis, panuveitis 
and acute retinal 
necrosis (ARN) [10]. 
 
HSV keratitis is often a clinical diagnosis. But 
sometimes especially in difficult cases the specific 
diagnostic tests are vital. The detection of viral DNA 
by PCR is sensitive and better than virus isolation or 
antigen detection. The intraocular infection could be 
found by PCR of anterior chamber or vitreous fluids. 
The locally produced antibody could also be 
detected, and by comparing with total IgG, one can 
determine intraorbital antibody production. 
 
The antiviral medications are the mainstay of 
treatment in HSV infections. The decision on 
whether depends on the location, severity of infection 
and immune status of the patient. There are several 
topical medications include acyclovir and trifluridine, 
with acyclovir being the most widely used. The 
systemic antiviral medications, other than acyclovir, 
are valaciclovir and famciclovir. The topical 
antivirals are used to treat HSV blepharitis, 
conjunctivitis, infectious epithelial keratitis and used 
as prophylaxis to cover corticosteroid treatment of 
certain forms of keratitis. Oral medications are used 
in some cases of endotheliitis, severe cases of uveitis, 
in immunocompromised patients, paediatric patients 
not responding to topical treatment or as prophylaxis. 
Intravenous therapy is ususally preserved for patients 
with posterior site involvement, such as necrotising 
herpetic retinitis (NHR). 
 
Corticosteroids use for inflammation in HSV ocular 
disease are controversial as it may cause increased 
severity of the HSV infection by inhibiting the host 
immune response, however in some cases can be 
helpful in reducing scarring and neovascularisation. 
 
Cytomegalovirus 
 
The first time CMV was isolated was in 1956 after 
cell culture technology was developed. The name is 
derived from the cytopathic effect seen in cell 
culture, i.e. ‘cytomegaly’ [11]. The virus could be 
transmitted vertically or horizontally and is shed 
frommultiple sites. Risk factors for severe disease 
involve primary infection, high viral load and 
immune suppression [12]. 
 
Although CMV mainly causes retinitis, other eye 
presentations include anterior uveitis and corneal 
endotheliitis [13]. There are as well reports of ARN 
being caused by CMV [14]. CMV retinitis often 
happens in advanced HIV disease, alone, with 
disseminated CMV disease or with immune 
reconstitution after initiation of HAART [15].  
 
The diagnosis of CMV retinitis is often a clinical one, 
however more lab tests might help in the diagnosis 
and involve serum antibody testing, viral isolation 
and PCR of blood or ocular fluids looking for CMV 
DNA [16]. 
 
The management of CMV retinitis involves 
beginning with an antiviral medication, which can be 
given systemically, as an intravitreal injection or as a 
long-acting intravitreal implant, in addition to 
HAART. The systemic antiviral medications involve 
the nucleoside analogue ganciclovir and its prodrug 
valganciclovir. There are as well Ganciclovir-
resistant mutants and are often the result of a 
mutation in the unique long ninety seven region of 
the genome [17].  
 
Intravitreal cidofovir may precipitate hypotony and 
so is generally avoided. Ganciclovir intravitreal 
implants have been shown to provide effective 
treatment of CMV retinitis. 
 
Varicella zoster virus 
 
VZV is transmitted through respiratory pathway and 
is very contagious. After the primary infection, the 
virus stays latent in one or more posterior root 
ganglia, often the trigeminal or thoracic nerves. The 
ophthalmic branch of the trigeminal nerve is the most 
commonly affected is its three divisions. About ten to 
twenty percentof all herpes zoster manifests as herpes 
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zoster ophthalmicus [18]. 
 
During times of low immunity, the virus could 
reactivate and spread from the ganglia down the 
peripheral nerves to the skin, to cause the typical 
lesions of herpes zoster. Acute retinal necrosis is also 
reported in older patients, The management of VZV 
infection is usually aimed to manage the symptoms, 
till the recovery and avoid complications. In addition 
to analgesia, good hydration and adequate personal 
hygiene to avoid secondary bacterial infection, there 
are 3 antiviral medications used in VZV infection.  
 
Epstein–Barr virus 
 
Primary infection generally happens after contact 
with the saliva [19]. EBV usually infects the B-cells 
however it can also infect some types of squamous 
epithelial cells. 
Some studies concluded wide range of manifestations 
of corneal epithelial and stromal infections associated 
with EBV, however the most frequent eye 
presentations of  acute mononucleosis include 
periorbital oedema and follicular conjunctivitis [20].  
 
Other Herpesviruses 
 
The other less common Herpesviruses causing eye 
disease are HHV-6 and HHV-8, with the latter also 
known as Kaposi sarcoma-associated Herpesvirus. 
HHV-6 seldom causes optic neuritis and could cause 
conjunctivitis. HHV-8 might cause conjunctival 
Kaposi’s sarcoma and possibly uveitis. 
 
Adenovirus 
 
Adenoviruses are part of the Adenoviridae family and 
are a wide range of double-stranded DNA viruses, 
that can cause a wide variety of diseases. These 
variety from upper and lower respiratory tract 
infections, to viral conjunctivitis, to gastroenteritis 
and others. These viruses are non-enveloped and thus 
are particularly resistant to inactivation and can 
survive in the environment for prolonged periods.  
Eye manifestations of adenoviral infection are 
categorized into four syndromes: 
pharyngoconjunctival fever (PCF), epidemic 
keratoconjunctivitis (EKC), acute nonspecific 
follicular conjunctivitis (NFC) and chronic 
keratoconjunctivitis (CKC) [21]. 
In addition, adenovirus might be the cause of acute 
haemorrhagic conjunctivitis. 
Pharyngoconjunctival fever is most frequently found 
in children and is generally due to serotype 3, but 
serotypes 1, 4, 5, 6, 7 and 14 have also been 
identified. 
 
Epidemic keratoconjunctivitis is most frequently 
associated with serotypes eight and nineteen, 
although it has also been reported with serotypes 2, 3, 
4, 7 to 11, 14, 16 and 29. The condition is very 
contagious and is most frequently in fall and winter. 
Acute nonspecific follicular conjunctivitis produces a 
mild conjunctivitis and is usually self-limiting.  
 
Management of keratitis and uveitis secondary to 
severe adenoviral conjunctivitis is managed with 
topical steroids but must be supervised.  
 
Enteroviruses 
 
Enteroviruses are members of the Picornaviridae 
family of single-stranded RNA viruses, that replicate 
in the intestinal tract and cause asymptomatic 
infection or mild symptoms. However in some cases 
the virus might travel to other organs, causing severe 
disease. These include ocular diseases such as 
conjunctivitis, keratoconjunctivitis and uveitis [22].  
 
Topical steroids must not be used, that is due to  the 
risk of corneal perforation. 
Parechovirus, which previously was under the human 
enteroviruses, has been isolated from ocular fluids in 
patients with uveitis [23]. 
 
Rubella 
 
Rubella (German measles) was first described as a 
distinct disease in the late 19th century. In general 
rubella virus causes a mild exanthematous disease 
that affects all ages [24]. Damage to fetal endothelial 
cells in early pregnancy is the result of viral 
replication, because the immune system has not 
developed by this time. The virus can also induces 
retardation of mitosis in infected cells. 
 
The goal of treatment of congenital rubella is at 
managing the complications, like cataract surgery and 
management of secondary glaucoma. If acquired 
following labor, which is generally in the form of 
conjunctivitis or keratitis, symptomatic treatment 
might be necessary, however the condition is usually 
self-limiting. 
 
Measles 
 
Measles viruses are a member of the 
Paramyxoviridae family of single-stranded RNA 
viruses, which spreads through the respiratory route 
and is very contagious [25]. After an incubation 
period of eight to twelve days, the symptoms of 
fever, cough, coryza and conjunctivitis begin. The 
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typical measles rash lasts for three to seven days.  
 
Measles is the most critical cause of blindness in 
pediatric population in developing countries. Acute 
MV infection decreases the serum retinol 
concentration, which could present as xerophthalmia 
and finally result in blindness. Blindness could also 
result from cortical damage from measles 
encephalitis. 
 
CONCLUSION: 
 
A wide range of of viruses can affect the eye and 
cause viral eye infections, either as a primary 
infection or reactivation. Some affect the eye directly 
while the others indirectly but may still manifest with 
eye disease. One virus may affect several parts of the 
eye, while different viruses may cause the same eye 
disease. This could complicate the clinical diagnosis 
of viral eye disease, but the lab tests like PCR and 
antibody tests could assist in challenging cases where 
there may be diagnostic dilemma. 
 
The HIV epidemic has had an huge impact on 
ophthalmology clinics, this is because the virus can 
cause different eye diseases, and the associated 
decrease in cell-mediated immunity makes the person 
highly susceptible to opportunistic viral eye 
infections, sometimes with severe morbidity. There 
could be other viruses that may affect the eye that we 
did not discuss. 
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